Nalu Medical is a US medical device company that commercializes alternative proprietary neuromodulation systems. These systems treat chronic neuropathic pain in the back, legs, and other peripheral parts of the body, affecting 1.5 million patients.

Nalu’s miniaturized implantable pulse generator (micro-IPG) is designed to mitigate the traditional challenges with implantable neurostimulation therapy, which often involve opiates and expensive nerve blocks, eliminating the need for battery replacement surgery. Its minimally invasive, patient-centric approach is designed to fit the patient’s lifestyle and includes an extensive range of advanced waveform therapy options, controlled discreetly via a smartphone app. The external therapy disc is easy to change and allows patients to manage their pain more comfortably.

Gilde Healthcare invested in Nalu in 2022 to support the company’s continued commercial expansion, clinical evidence generation, and further product innovation to help more patients manage chronic pain.